Agilent Technologies Inc. Introduces Workflow HPLC-Chip for Biopharmaceutical Analysis

SALT LAKE CITY--(BUSINESS WIRE)--ASMS 2010--Agilent Technologies Inc. (NYSE:A) today introduced a new HPLC-Chip to address N-glycan analysis in the emerging biopharmaceutical market.

MORE ON THIS TOPIC